Cargando…

Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study

BACKGROUND: Proton pump inhibitors (PPIs) are among the most widely prescribed medications in clinical practice. However, there are also concerns about the potential risks of long-term PPI use. The present study aimed to examine the safety of PPIs and summarize their potential cardiac and vascular r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Yinghong, Ye, Xiaofei, Hu, Fangyuan, Xu, Jinfang, Guo, Xiaojing, Lin, Zhen, Zhou, Xiang, Guo, Zhijian, Cao, Yang, He, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913586/ https://www.ncbi.nlm.nih.gov/pubmed/35282344 http://dx.doi.org/10.3389/fcvm.2022.767987

Ejemplares similares

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States
por: Zhai, Yinghong, et al.
Publicado: (2021)

Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
por: Zhai, Yinghong, et al.
Publicado: (2019)

Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database
por: Hu, Fangyuan, et al.
Publicado: (2021)

Metabolic and Nutritional Disorders Following the Administration of Immune Checkpoint Inhibitors: A Pharmacovigilance Study
por: Zhai, Yinghong, et al.
Publicado: (2022)

Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS
por: Zhou, Xiang, et al.
Publicado: (2021)

Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data
por: Ahmad, Javaria, et al.
Publicado: (2022)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
por: Chen, Chenxin, et al.
Publicado: (2021)

Updated insights on dementia‐related risk of sacubitril/valsartan: A real‐world pharmacovigilance analysis
por: Chen, Congqin, et al.
Publicado: (2023)

A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
por: Wu, Bin, et al.
Publicado: (2021)

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database
por: Zheng, Yi, et al.
Publicado: (2023)

Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications
por: Masiero, Giulia, et al.
Publicado: (2022)

An update on the Pharmacovigilance Programme of India
por: Lihite, Ratan J., et al.
Publicado: (2015)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
por: Guo, Menglin, et al.
Publicado: (2022)

Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study
por: Wang, Mengmeng, et al.
Publicado: (2022)

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
por: Xie, Juntao, et al.
Publicado: (2022)

A New Era in Pharmacovigilance: Toward Real‐World Data and Digital Monitoring
por: Lavertu, Adam, et al.
Publicado: (2021)

A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
por: Zhang, Qilin, et al.
Publicado: (2023)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
por: Xie, Juntao, et al.
Publicado: (2022)

Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan
por: Howden, Colin W., et al.
Publicado: (2023)

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS
por: Feng, Zhen, et al.
Publicado: (2022)

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
por: Jiang, Lin, et al.
Publicado: (2023)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
por: Wedemeyer, Ralph-Steven, et al.
Publicado: (2014)

Proton Pump Inhibitors and Bone Health: An Update Narrative Review
por: Lespessailles, Eric, et al.
Publicado: (2022)

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
por: Wang, Mei, et al.
Publicado: (2022)

An Update on the International Society of Pharmacovigilance China Chapter
por: Wen, Yalu, et al.
Publicado: (2022)

A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
por: Heitzinger, Gregor, et al.
Publicado: (2022)

Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation
por: Guo, Xue-Jun, et al.
Publicado: (2023)

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies
por: Hsu, Po-Yen, et al.
Publicado: (2021)

An analysis of real-world cost-effectiveness of TAVI in South Africa
por: Mabin, Thomas A, et al.
Publicado: (2014)

Real-World and Regulatory Perspectives of Artificial Intelligence in Cardiovascular Imaging
por: Wellnhofer, Ernst
Publicado: (2022)

Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
por: Gozzo, Lucia, et al.
Publicado: (2017)

Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
por: Wang, Li, et al.
Publicado: (2021)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
por: Wu, Yan, et al.
Publicado: (2023)

Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review
por: Edinoff, Amber N., et al.
Publicado: (2023)

Real-world Bleeding Outcomes and Costs Following Vascular Graft Anastomosis Using PROLENE Sutures with HEMO-SEAL Technology in Patients Undergoing Abdominal Aortic Aneurysm Repair
por: Sutton, Nadia Y., et al.
Publicado: (2017)

Transcatheter Aortic Valve Implantation: All Transfemoral? Update on Peripheral Vascular Access and Closure
por: Perrin, Nils, et al.
Publicado: (2021)

Editorial: Transcatheter Aortic Valve Implantation: All Transfemoral? Update on Vascular Acccess and Closure
por: Cerillo, Alfredo Giuseppe, et al.
Publicado: (2022)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

The history and mystery of sacubitril/valsartan: From clinical trial to the real world
por: Zhang, Mingsong, et al.
Publicado: (2023)

On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
por: Battini, Vera, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_96657pfff3fo3cq0jvnnnf66ik